| abstract |
The invention relates to a method of producing an antibody or an antibody fragment specifically recognizing a peptide-MHC complex. It also relates to antibodies and antibody fragments according to the invention which are conjugated to a pharmaceutical or to a superantigen. Furthermore, the invention relates to a pharmaceutical composition comprising antibodies or antibody fragments according to the invention for the prevention or treatment of infectious and autoimmune diseases, and cancer, and to compositions for the diagnosis of said diseases. |